Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Kisqali Global Growth at Constant Currencies by Year
Kisqali Global Growth at Constant Currencies (% cc) (%)
Novartis Kisqali Global Growth at Constant Currencies: 57.0% in FY2025, up 8.0 pts from a year earlier.
Latest, FY2025
57.0%
Period ended Dec 31, 2025
Change on a year earlier
+8.0 pts
49.0% in FY2024
History
7 years
Since FY2018
Sources
7
Documents cited below
Where the FY2025 figure comes from
“|| Kisqali | 4 783 | 3 033 | 58 | 57”
Source: Novartis Form 6-K (0001114448-26-000007) ↗
Reported in Form 6-K & Form 20-F.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Kisqali Global Growth at Constant Currencies (% cc) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 57.0% | +8.0 pts | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2024 | Dec 31, 2024 | 49.0% | -26.0 pts | Novartis Form 6-K (0001370368-25-000007) ↗ |
| FY2023 | Dec 31, 2023 | 75.0% | +37.0 pts | Novartis Form 6-K (0001370368-24-000007) ↗ |
| FY2022 | Dec 31, 2022 | 38.0% | – | Novartis Form 6-K (0001370368-23-000008) ↗ |
| FY2020 | Dec 31, 2020 | 45.0% | -66.0 pts | Novartis Form 6-K (0001370368-21-000008) ↗ |
| FY2019 | Dec 31, 2019 | 111.0% | -99.0 pts | Novartis Form 6-K (0001370368-20-000007) ↗ |
| FY2018 | Dec 31, 2018 | 210.0% | – | Novartis Form 6-K (0001370368-19-000006) ↗ |
Cite this data
StockData. (2026). Novartis Kisqali Global Growth at Constant Currencies (%), annual FY2018–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-kisqali-yoy-cc-pct
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.